JP2014520786A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520786A5 JP2014520786A5 JP2014517820A JP2014517820A JP2014520786A5 JP 2014520786 A5 JP2014520786 A5 JP 2014520786A5 JP 2014517820 A JP2014517820 A JP 2014517820A JP 2014517820 A JP2014517820 A JP 2014517820A JP 2014520786 A5 JP2014520786 A5 JP 2014520786A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173066.9 | 2011-07-07 | ||
| EP11173066 | 2011-07-07 | ||
| PCT/EP2012/063242 WO2013004816A1 (en) | 2011-07-07 | 2012-07-06 | Darunavir formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520786A JP2014520786A (ja) | 2014-08-25 |
| JP2014520786A5 true JP2014520786A5 (enExample) | 2015-07-16 |
| JP6101260B2 JP6101260B2 (ja) | 2017-03-22 |
Family
ID=46458539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517820A Active JP6101260B2 (ja) | 2011-07-07 | 2012-07-06 | ダルナビル製剤 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20140142174A1 (enExample) |
| EP (1) | EP2729128B1 (enExample) |
| JP (1) | JP6101260B2 (enExample) |
| KR (1) | KR101817991B1 (enExample) |
| CN (1) | CN103841962B (enExample) |
| AU (1) | AU2012280277B2 (enExample) |
| BR (1) | BR112014000195A2 (enExample) |
| CA (1) | CA2837539C (enExample) |
| CY (1) | CY1119446T1 (enExample) |
| DK (1) | DK2729128T3 (enExample) |
| EA (1) | EA026588B1 (enExample) |
| ES (1) | ES2598823T3 (enExample) |
| HR (1) | HRP20161340T1 (enExample) |
| HU (1) | HUE030341T2 (enExample) |
| IL (1) | IL229700B (enExample) |
| LT (1) | LT2729128T (enExample) |
| MX (1) | MX341976B (enExample) |
| PL (1) | PL2729128T3 (enExample) |
| PT (1) | PT2729128T (enExample) |
| RS (1) | RS55236B1 (enExample) |
| SI (1) | SI2729128T1 (enExample) |
| SM (1) | SMT201600380B (enExample) |
| WO (1) | WO2013004816A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2729130T (pt) | 2011-07-07 | 2017-12-13 | Gilead Sciences Inc | Formulações de combinação de darunavir |
| HK1220390A1 (zh) | 2013-08-29 | 2017-05-05 | Teva Pharmaceutical Industries Ltd. | 包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂 |
| JP5843986B2 (ja) * | 2014-03-25 | 2016-01-13 | アステラス製薬株式会社 | 粒状医薬組成物 |
| WO2015155673A1 (en) | 2014-04-08 | 2015-10-15 | Teva Pharmaceutical Industries Ltd | Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir |
| EP3210017B1 (en) | 2014-10-26 | 2021-10-06 | King Abdullah University Of Science And Technology | Alkaloids from sponge, scaffolds for the inhibition of human immunodeficiency virus (hiv) |
| BR112020000842A2 (pt) | 2017-07-20 | 2020-07-21 | Janssen Sciences Ireland Unlimited Company | composições e métodos para tratamento do hiv |
| US20200101093A1 (en) | 2018-09-28 | 2020-04-02 | Janssen Sciences Ireland Unlimited Company | Methods of Treating and Preventing Neuropsychiatric and/or Neurocognitive Complications in Patients Infected with HIV |
| US20210290590A1 (en) | 2020-03-13 | 2021-09-23 | Janssen Sciences Ireland Unlimited Company | Methods of treating subjects infected with hiv |
| US11311559B2 (en) * | 2020-04-20 | 2022-04-26 | Poviva Corp. | Compositions and methods for enhanced delivery of antiviral agents |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| WO1995006030A1 (en) | 1993-08-24 | 1995-03-02 | G.D. Searle & Co. | Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| AU771780B2 (en) | 1998-06-23 | 2004-04-01 | Board Of Trustees Of The University Of Illinois, The | Fitness assay and associated methods |
| AR037797A1 (es) | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | Combinacion de inhibidores de proteasa dependientes del citocromo p450 |
| RU2010102067A (ru) * | 2007-06-25 | 2011-07-27 | Тиботек Фармасьютикалз (Ie) | Комбинированные композиции, включающие дарунавир и этравирин |
| AR069539A1 (es) * | 2007-07-25 | 2010-02-03 | Tibotec Pharm Ltd | Avances respecto de las formulaciones de comprimidos contra el vih |
| PA8809601A1 (es) * | 2007-12-24 | 2009-07-23 | Cipla Ltd | Combinación anti-retroviral |
| PT2477992T (pt) * | 2009-09-17 | 2017-03-20 | Mylan Laboratories Ltd | Processos para a preparação de darunavir e a forma amorfa do mesmo |
-
2012
- 2012-07-06 HU HUE12732668A patent/HUE030341T2/en unknown
- 2012-07-06 WO PCT/EP2012/063242 patent/WO2013004816A1/en not_active Ceased
- 2012-07-06 JP JP2014517820A patent/JP6101260B2/ja active Active
- 2012-07-06 RS RS20160872A patent/RS55236B1/sr unknown
- 2012-07-06 EP EP12732668.4A patent/EP2729128B1/en active Active
- 2012-07-06 CA CA2837539A patent/CA2837539C/en active Active
- 2012-07-06 LT LTEP12732668.4T patent/LT2729128T/lt unknown
- 2012-07-06 DK DK12732668.4T patent/DK2729128T3/en active
- 2012-07-06 AU AU2012280277A patent/AU2012280277B2/en active Active
- 2012-07-06 KR KR1020147000084A patent/KR101817991B1/ko active Active
- 2012-07-06 PT PT127326684T patent/PT2729128T/pt unknown
- 2012-07-06 US US14/131,272 patent/US20140142174A1/en not_active Abandoned
- 2012-07-06 PL PL12732668T patent/PL2729128T3/pl unknown
- 2012-07-06 EA EA201490223A patent/EA026588B1/ru unknown
- 2012-07-06 HR HRP20161340TT patent/HRP20161340T1/hr unknown
- 2012-07-06 SI SI201230742A patent/SI2729128T1/sl unknown
- 2012-07-06 BR BR112014000195A patent/BR112014000195A2/pt not_active Application Discontinuation
- 2012-07-06 MX MX2013015196A patent/MX341976B/es active IP Right Grant
- 2012-07-06 ES ES12732668.4T patent/ES2598823T3/es active Active
- 2012-07-06 CN CN201280033515.0A patent/CN103841962B/zh active Active
-
2013
- 2013-11-28 IL IL229700A patent/IL229700B/en active IP Right Grant
-
2016
- 2016-01-07 US US14/990,621 patent/US20160113949A1/en not_active Abandoned
- 2016-10-25 CY CY20161101073T patent/CY1119446T1/el unknown
- 2016-10-26 SM SM201600380T patent/SMT201600380B/it unknown
-
2021
- 2021-04-27 US US17/242,218 patent/US20210244749A1/en not_active Abandoned